The Effect of Edaravone Supplementation Prior to Cryopreservation on Sperm Parameters, DNA Integrity, Apoptosis, Lipid Peroxidation, and Mitochondrial Membrane Potential in Infertile Men with Asthenoteratozoospermia.

IF 2.6 3区 医学 Q2 OBSTETRICS & GYNECOLOGY
Reproductive Sciences Pub Date : 2025-04-01 Epub Date: 2025-02-21 DOI:10.1007/s43032-024-01754-x
Mohammadrasool Ghasemi, Hamid Nazarian, Zahra Shams Mofarahe, Pourya Raee, Ali Moradi, Zohreh Khavari, Marefat Ghaffari Novin
{"title":"The Effect of Edaravone Supplementation Prior to Cryopreservation on Sperm Parameters, DNA Integrity, Apoptosis, Lipid Peroxidation, and Mitochondrial Membrane Potential in Infertile Men with Asthenoteratozoospermia.","authors":"Mohammadrasool Ghasemi, Hamid Nazarian, Zahra Shams Mofarahe, Pourya Raee, Ali Moradi, Zohreh Khavari, Marefat Ghaffari Novin","doi":"10.1007/s43032-024-01754-x","DOIUrl":null,"url":null,"abstract":"<p><p>Male infertility is a worldwide problem, and many couples have suffered from it. Although cryopreservation is widely used for the long-term preservation of human sperm, sperm survival, and function post-thawing procedure may be strongly impaired and thus decrease the reproductive performance. This study examined whether adding Edaravone before cryopreservation could improve the post-thaw parameters (especially sperm motility) of cryopreserved spermatozoa in patients with asthenoteratozoospermia (AT). Semen samples were collected by masturbation from 25 men with AT and assessed following WHO standards. Samples were divided into three aliquots. The first aliquot remained untreated and freshly assessed (fresh group). The second aliquot was untreated, mixed with a cryopreservation medium, and cryopreserved (freeze group). The third aliquot was treated with ten µM Edaravone, mixed with cryopreservation medium, and cryopreserved (freeze + Edaravone group). The groups were assessed for motility, morphology, viability, apoptosis, lipid peroxidation, Mitochondrial Membrane Potential (MMP), DNA Fragmentation Index (DFI), glutathione (GSH), ATP, and ROS production. The freeze + Edaravone group significantly improved total sperm motility (P < 0.0001), progressive and non-progressive sperm motility (P < 0.01), viability (P < 0.0001), morphology (P < 0.001), DFI (P < 0.0001) and live sperm cells (P < 0.0001) post-thawing compared to freeze group. Additionally, the freeze + Edaravone group significantly decreased necrotic sperm cells (P < 0.0001), lipid peroxidation (P < 0.0001), and intracellular ROS production (P < 0.0001) post-thawing procedure. Furthermore, the freeze + Edaravone group significantly enhanced MMP jc-1 orange and green (P < 0.0001 and P < 0.01, respectively), ATP production (P < 0.0001), and GSH levels (P < 0.0001) post-thawing procedure compared to freeze group. Our findings proved that the freeze + Edaravone group of men with AT improved sperm survival and functions post-thawing procedure.</p>","PeriodicalId":20920,"journal":{"name":"Reproductive Sciences","volume":" ","pages":"1092-1101"},"PeriodicalIF":2.6000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s43032-024-01754-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/21 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Male infertility is a worldwide problem, and many couples have suffered from it. Although cryopreservation is widely used for the long-term preservation of human sperm, sperm survival, and function post-thawing procedure may be strongly impaired and thus decrease the reproductive performance. This study examined whether adding Edaravone before cryopreservation could improve the post-thaw parameters (especially sperm motility) of cryopreserved spermatozoa in patients with asthenoteratozoospermia (AT). Semen samples were collected by masturbation from 25 men with AT and assessed following WHO standards. Samples were divided into three aliquots. The first aliquot remained untreated and freshly assessed (fresh group). The second aliquot was untreated, mixed with a cryopreservation medium, and cryopreserved (freeze group). The third aliquot was treated with ten µM Edaravone, mixed with cryopreservation medium, and cryopreserved (freeze + Edaravone group). The groups were assessed for motility, morphology, viability, apoptosis, lipid peroxidation, Mitochondrial Membrane Potential (MMP), DNA Fragmentation Index (DFI), glutathione (GSH), ATP, and ROS production. The freeze + Edaravone group significantly improved total sperm motility (P < 0.0001), progressive and non-progressive sperm motility (P < 0.01), viability (P < 0.0001), morphology (P < 0.001), DFI (P < 0.0001) and live sperm cells (P < 0.0001) post-thawing compared to freeze group. Additionally, the freeze + Edaravone group significantly decreased necrotic sperm cells (P < 0.0001), lipid peroxidation (P < 0.0001), and intracellular ROS production (P < 0.0001) post-thawing procedure. Furthermore, the freeze + Edaravone group significantly enhanced MMP jc-1 orange and green (P < 0.0001 and P < 0.01, respectively), ATP production (P < 0.0001), and GSH levels (P < 0.0001) post-thawing procedure compared to freeze group. Our findings proved that the freeze + Edaravone group of men with AT improved sperm survival and functions post-thawing procedure.

冷冻保存前补充依达拉奉对精子参数、DNA完整性、细胞凋亡、脂质过氧化和线粒体膜电位的影响
男性不育是一个世界性问题,许多夫妇都深受其害。尽管低温冷冻被广泛用于长期保存人类精子,但精子在解冻后的存活率和功能可能会受到严重影响,从而降低生殖能力。本研究探讨了在冷冻保存前添加依达拉奉是否能改善无精子症(AT)患者冷冻保存精子的解冻后参数(尤其是精子活力)。研究人员通过手淫采集了 25 名男性无精子症患者的精液样本,并按照世界卫生组织的标准对样本进行了评估。样本被分成三个等分。第一份等分样本未经处理,并进行了新鲜评估(新鲜组)。第二份等分样本未经处理,与低温保存培养基混合后进行低温保存(冷冻组)。第三份等分样品经 10 µM 依达拉奉处理后,与冷冻保存培养基混合并冷冻保存(冷冻 + 依达拉奉组)。对各组的运动、形态、活力、凋亡、脂质过氧化、线粒体膜电位(MMP)、DNA 断裂指数(DFI)、谷胱甘肽(GSH)、ATP 和 ROS 生成进行评估。冷冻+依达拉奉组明显改善了精子的总活力(P
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Reproductive Sciences
Reproductive Sciences 医学-妇产科学
CiteScore
5.50
自引率
3.40%
发文量
322
审稿时长
4-8 weeks
期刊介绍: Reproductive Sciences (RS) is a peer-reviewed, monthly journal publishing original research and reviews in obstetrics and gynecology. RS is multi-disciplinary and includes research in basic reproductive biology and medicine, maternal-fetal medicine, obstetrics, gynecology, reproductive endocrinology, urogynecology, fertility/infertility, embryology, gynecologic/reproductive oncology, developmental biology, stem cell research, molecular/cellular biology and other related fields.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信